Checkpoint Therapeutics

Youtube Subscribe

Open: 1.99 Close: 1.92 Change: -0.07

Can you guess what an AI found about Checkpoint Therapeutics Company Inc Stock.

Are looking for the most relevant information about Checkpoint Therapeutics? Investor spend a lot of time searching for information to make investment decisions in Checkpoint Therapeutics. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Checkpoint Therapeutics are: share, Checkpoint, Therapeutics, direct, company, offering, price, and the most common words in the summary are: checkpoint, therapeutic, stock, immune, globenewswire, inc, top, . One of the sentences in the summary was: Oncology company will issue about 7.8M shares at $1.805. Other searches …

Concept Map

Semantic Network

Stock Summary

Checkpoint Therapeutics, Inc. focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company was incorporated in 2014 and is based in Waltham, Massachusetts..

Today's Summary

Checkpoint Therapeutics shares rise 17% after direct offering prices. Oncology company will issue about 7.8M shares at $1.805. Pomerantz LLP is investigating claims on behalf of investors.

Today's News

Checkpoint Therapeutics shares rise 17% after direct offering prices - marketwatch.com. Checkpoint shares were up 17% to $1.97 after the company entered into a definitive agreement with a single healthcare-dedicated institutional investor for the issuance and sale of 7.8 million shares at $1805 a share in a registered direct offering priced at-the-market. The company has a Bearish sentiment reading on boxing force sidesudi supplementigent idle Hansenranging OutlookMail Checkpoint Therapeutics, Inc. (CKPT) Stock by: Mary Christine Joy , SA News Editor 2 Comments DNY59. Oncology company will issue about 7.8M shares at $1.805. Checkpoint Therapeutics sells 7.76M shares at $1.805 in registered direct offer. Pomerantz LLP is investigating claims on behalf of investors.

Stock Profile

"Checkpoint Therapeutics, Inc., a clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to programmed death ligand-1 (PD-L1) and blocks the PD-L1 interaction with the programmed death receptor-1 and B7.1 receptors; and CK-302, a human agonistic antibody that is designed to bind to and trigger signaling in GITR expressing cells. It is also developing Olafertinib, a third-generation epidermal growth factor receptor (EGFR) inhibitor, as a treatment for patients with EGFR mutation-positive non-small cell lung cancer; CK-103, a selective and potent small molecule inhibitor of bromodomain and extra-terminal bromodomains; and anti-carbonic anhydrase IX (CAIX) antibody, a fully human preclinical antibody to recognize CAIX expressing cells and kill them via antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity. The company has collaboration agreements with TG Therapeutics, Inc. to develop and commercialize certain assets in connection with its licenses in the field of hematological malignancies. The company was incorporated in 2014 and is based in Waltham, Massachusetts. Checkpoint Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc."

Keywords

How much time have you spent trying to decide whether investing in Checkpoint Therapeutics? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Checkpoint Therapeutics are: share, Checkpoint, Therapeutics, direct, company, offering, price, and the most common words in the summary are: checkpoint, therapeutic, stock, immune, globenewswire, inc, top, . One of the sentences in the summary was: Oncology company will issue about 7.8M shares at $1.805. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #checkpoint #therapeutic #stock #immune #globenewswire #inc #top.

Read more →

Youtube Subscribe

---